Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)

A legfontosabb adatok

Ki végzi
Medtronic Cardiovascular
Hol
Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
142 fő, tervezett
Kezdés
2026. aug. 26.
Várható befejezés
2030. aug.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Heli-FX EndoAnchor System
A regiszteradat frissítve
2026. szeptember 14.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with an abdominal aortic aneurysm (a bulge in the main belly artery) planned for non-urgent repair. Their aneurysm shape must carry a high risk of leaks or graft movement. The trial tests the Heli-FX EndoAnchor System.

Életkor
18 years or older
Nem
Men and women. Women cannot be pregnant. Women who could become pregnant need a negative pregnancy test before joining.
A betegség stádiuma
Aneurysm at least 4.5 cm (1,8 in) wide in women or at least 5 cm (2 in) in men. Neck of the aneurysm 19 to 32 mm wide. Set limits on artery size, length and angles apply. At least one high-risk shape feature, such as a neck wider than 28 mm, a short neck (10 to under 15 mm), a neck angle of 60° to 75°, or a cone-shaped neck. Or the doctor judges the person could benefit. The doctor must judge that the person can have planned aneurysm repair. Life expectancy over 2 years.
Korábbi kezelés
People cannot join if they have had earlier repair of their abdominal aortic aneurysm.

A részvétel fő kizáró okai

  • Aneurysm that has burst or is leaking, or that needs emergency repair
  • Heart attack within the past 3 months, or body-wide infection
  • Kidney failure needing dialysis
  • Inherited connective tissue disease such as Marfan or Ehlers-Danlos syndrome, or an aneurysm in the chest aorta too
  • Unable to stop blood thinners for the procedure, or allergy to the device metals or contrast dye

A regiszter feltételei, szó szerint

Mind a 33 feltétel megnézéseKevesebb

Ki vehet részt

  • Aged 18 years or older
  • Male or non-pregnant female patients; women of childbearing potential must undergo a pregnancy test prior to enrollment, and the result must be negative
  • Willing and able to provide written informed consent
  • Maximum diameter of the abdominal aortic aneurysm (AAA) ≥ 4.5 cm in females or ≥ 5 cm in males
  • Proximal neck diameter of the AAA ranging from 19 to 32 mm
  • Distal fixation zone length of both iliac arteries ≥ 15 mm
  • Diameter of iliac artery fixation zones on both sides ranging from 8 to 25 mm
  • ≤ 60° infrarenal and ≤ 45°suprarenal angulation OR ≤ 75°infrarenal and ≤ 60°suprarenal angulation with proximal necks ≥ 15 mm in length
  • Presence of high-risk anatomical criteria, defined as meeting any one of the following criteria:; Proximal neck diameter > 28 mm and ≤ 32mm; Proximal neck length ≥ 10 mm and < 15 mm; Neck angulation ≥ 60°and ≤ 75° (angle between the long axis of the proximal neck and the long axis of the aneurysm sac); Conical neck (defined as diameter increased > 10% compared with the immediate infrarenal diameter over the first 10 mm beyond the lowest main renal artery); Investigator determined subject could benefit from this Heli-FX procedure
  • Patients deemed by the investigator to be suitable candidates for elective AAA repair
  • Patients who agree to return to the treating investigator for all scheduled follow-up visits and are able to attend hospital-based follow-up
  • Life expectancy > 2 years

Ki nem vehet részt

  • Concomitant thoracic aortic aneurysm or thoracoabdominal aortic aneurysm
  • History of prior AAA repair
  • Planned major surgery (e.g., thoracic aorta, renal, superior mesenteric artery/celiac or lower extremity revascularization, IMA reimplantation, permanent vascular access, cholecystectomy) concurrent with or within 30 days before or after the AAA repair procedure
  • Patients who cannot discontinue oral anticoagulation or antiplatelet therapy at the time of the study procedure
  • Irregularly shaped calcification and/or plaques at the proximal implantation sites that may interfere with proper deployment of the EndoAnchor implants
  • Participation in another investigational drug or device trial without having completed the required follow-up
  • Endograft planned to be used had not undergone in vitro evaluation to confirm its compatibility with the EndoAnchor implant and the aortic fixation system
  • Myocardial infarction within the past 3 months
  • Systemic infection
  • Infected or inflammatory AAA
  • Known hereditary connective tissue disorders (e.g., Marfan syndrome or Ehlers-Danlos syndrome)
  • Renal failure requiring dialysis
  • Known hypersensitivity or allergy to polyester, nickel, titanium, tantalum, chromium, molybdenum, and/or cobalt
  • Bleeding diathesis or hypercoagulable state
  • Mental disorders or other conditions that may impair the patient's ability to understand the nature, significance, and/or scope of the study
  • Patient has a known hypersensitivity or contraindication to anticoagulants, anti-platelets, or contrast media, which is not amenable to pre-treatment
  • Sealing zone thrombus, calcium or plaque > 2 mm in thickness or covering > 50% (180 degrees) of the vessel circumference
  • Ruptured or leaking AAA
  • Requirement for emergency AAA repair
  • Patient body habitus that interferes with required imaging studies
  • In the opinion of the investigator, the patient has serious comorbidities that may pose an unacceptable risk for general anesthesia or endovascular intervention

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.

A vizsgálat csoportja

  • Heli-FXA vizsgált kezelés

    Kezelés: Heli-FX EndoAnchor System

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. szeptember 14.